Maria V. Barron
Financieel Directeur/CFO bij The Art Institute of Fort Lauderdale
Profiel
Maria V.
Barron is currently the Director of Administrative & Financial Services at The Art Institute of Fort Lauderdale.
Previously, she worked as an Administration Director at Altheos, Inc.
Actieve functies van Maria V. Barron
| Bedrijven | Functie | Begin |
|---|---|---|
The Art Institute of Fort Lauderdale
 The Art Institute of Fort Lauderdale Other Consumer ServicesConsumer Services The Art Institute of Fort Lauderdale (AiFL) was established in September1968 and provides training for a wide variety of professional fields involving the creative arts. The school's career-oriented curriculum offers bachelor's degrees, associate degrees and diplomas in everything from advertising and broadcasting to photography and yacht design. The college is one of a member institutions in The Art Institutes System which is a subsidiary of Education Management Corporation. | Financieel Directeur/CFO | - |
Eerdere bekende functies van Maria V. Barron
| Bedrijven | Functie | Einde |
|---|---|---|
Altheos, Inc.
 Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Hoofd Administratief Officier | 18-11-2013 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Altheos, Inc.
Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Health Technology |
